Open licensing vs Monopoly Controlled Supply

One of the most important battles being waged both inside and outside of the IGWG concerns the nature of competition for the supply of inexpensive medicines and vaccines.

The large pharma companies with well-known brands and big marketing and distribution systems want to marginalize developing country generic suppliers, as actual or potential competitors. This plays out in various ways. For example:

Continue Reading